SEOUL, South Korea, June 12, 2025 /PRNewswire/ — Mezzion Pharma Co., Ltd. (Mezzion), a leader in rare disease therapeutics, today announced the expansion of its udenafil pipeline with the initiation of a pre-clinical study for Autosomal Dominant Polycystic Kidney Disease (ADPKD). This…
